Search research articles
Contact Us
Filters
Showing results (31-40 of 484) with videos related to
Page
of 49
Sort By:
Rheumatic Diseases Clinics of North America
|
March 11, 2008
Current approaches to the management of early active diffuse scleroderma skin disease
Svetlana I Nihtyanova, Christopher P Denton
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertension
J G Coghlan, Christopher P Denton
Current Opinion in Rheumatology
|
September 4, 2009
Disease-modifying treatment in systemic sclerosis: current status
Niamh P Quillinan, Christopher P Denton
Rheumatic Diseases Clinics of North America
|
July 5, 2003
Pulmonary hypertension in systemic sclerosis
Christopher P Denton, Carol M Black
American Journal of Respiratory and Critical Care Medicine
|
November 30, 2017
The Fine Line between Success and Failure in Scleroderma Lung Fibrosis Trials
Christopher J Ryerson, Christopher P Denton
Current Opinion in Rheumatology
|
March 2, 2010
Innovative therapies for systemic sclerosis
Voon H Ong, Christopher P Denton
Nature Reviews. Rheumatology
|
February 4, 2010
Autoantibodies as predictive tools in systemic sclerosis
Svetlana I Nihtyanova, Christopher P Denton
Nature Reviews. Rheumatology
|
October 1, 2014
Interstitial lung disease in connective tissue disease--mechanisms and management
Athol U Wells, Christopher P Denton
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Pathogenesis of systemic sclerosis associated interstitial lung disease
Svetlana I Nihtyanova, Christopher P Denton
American Journal of Respiratory and Critical Care Medicine
|
June 16, 2015
Molecular Phenotyping. A Guide to Improving Detection of Interstitial Lung Disease in Patients with Rheumatoid Arthritis
Rekha Vij, Christopher P Denton, Imre Noth
Page
of 49
Search research articles
Search
Showing results (31-40 of 484) with videos related to
Sort By:
Page
of 49
Rheumatic Diseases Clinics of North America
|
March 11, 2008
Current approaches to the management of early active diffuse scleroderma skin disease
Svetlana I Nihtyanova, Christopher P Denton
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertension
J G Coghlan, Christopher P Denton
Current Opinion in Rheumatology
|
September 4, 2009
Disease-modifying treatment in systemic sclerosis: current status
Niamh P Quillinan, Christopher P Denton
Rheumatic Diseases Clinics of North America
|
July 5, 2003
Pulmonary hypertension in systemic sclerosis
Christopher P Denton, Carol M Black
American Journal of Respiratory and Critical Care Medicine
|
November 30, 2017
The Fine Line between Success and Failure in Scleroderma Lung Fibrosis Trials
Christopher J Ryerson, Christopher P Denton
Current Opinion in Rheumatology
|
March 2, 2010
Innovative therapies for systemic sclerosis
Voon H Ong, Christopher P Denton
Nature Reviews. Rheumatology
|
February 4, 2010
Autoantibodies as predictive tools in systemic sclerosis
Svetlana I Nihtyanova, Christopher P Denton
Nature Reviews. Rheumatology
|
October 1, 2014
Interstitial lung disease in connective tissue disease--mechanisms and management
Athol U Wells, Christopher P Denton
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Pathogenesis of systemic sclerosis associated interstitial lung disease
Svetlana I Nihtyanova, Christopher P Denton
American Journal of Respiratory and Critical Care Medicine
|
June 16, 2015
Molecular Phenotyping. A Guide to Improving Detection of Interstitial Lung Disease in Patients with Rheumatoid Arthritis
Rekha Vij, Christopher P Denton, Imre Noth
Page
of 49